Question Bank › Ready-to-run scale already paid for and now fill

Ready-to-run scale already paid for and now filling

Ready-to-run scale already paid for and now filling: management describes a step-change capability recently completed an

Calls Tested
475
Answered YES
4
Hit Rate
0.8%
rare by design

Precipio, Inc. (PRPO) — this company's answers

NO on the Q3 2018 call 2018-11-19 D
The model's full reasoning — Q3 2018 call → NOWe need answer YES or NO based on transcript. Need identify if management describes recently finished putting in place a capability large relative to company, real business already flowing into it, most still unused. Let's parse transcript. Management discusses several things: ICP technology, pathology services, IV-Cell, HemeScreen. Need see if any fits. Key: "During the last quarter we continue to invest in our sales force and have hired top notch individuals. Our 10-member strong teams in Q3 have contributed to the growth in our customer base resulting as we've recently announced in our revenues from pathology services growing close to 50% from the previous quarter. With a substantial pipeline of new customers and strong conversion rates, we expect a continued rapid growth of this side of our business with revenues from pathology services alone exceeding $1 million per quarter by the middle of 2019." This is sales force hired, business flowing, but is it step-change capability? They hired 10-member team, but not described as finished and paid for? They continue to invest. Not clearly "capability" with most unused. Another: "During this quarter, we also announced another new technology we developed called HemeScreen; ... Since the launch of the test in our lab, only two weeks ago, we've already received numerous orders -- we've already run numerous orders received from physicians. We believe that given the market volume and revenue numbers of the current inferior test, that HemeScreen can generate revenues in excess of $1 million in 2019 and rapidly increase in the following years. This is not including potential licensing and other partnerships we're currently working on to capture this $100 million U.S. market opportunity." This is a new test launched, real orders flowing, but is it a "capability" that is large relative to company? It's a new proprietary test, not a capacity. Also most unused? They expect growth but not say capacity underutilized. Another: "In Q3 the lab management successfully expanded it's in-house molecular testing capabilities. This expansion will all but eliminate the need for very expensive outsourcing that we have incurring for the last 5 or 6 quarters, and it will have an immediate impact on lab cost of goods." This is a capability expansion in lab, finished, paid for? It eliminates outsourcing.

← Back to the full PRPO analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management describe that the company has RECENTLY FINISHED PUTTING IN PLACE A CAPABILITY THAT IS LARGE RELATIVE TO THE COMPANY ITSELF, and that real business has ALREADY BEGUN FLOWING INTO IT while most of that capability still sits unused? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent situation in which all three of the following come through: (1) A STEP-CHANGE CAPABILITY THAT IS NOW FINISHED OR ESSENTIALLY FINISHED, AND ALREADY PAID FOR. Management describes something the company has built, bought, hired, licensed, approved, integrated, or otherwise stood up that materially raises the ceiling on how much business the company can do — and describes it as complete, commissioned, open, live, staffed, qualified, or in hand, with the money and effort behind it largely already spent. The capability may take whatever form fits the industry: a plant, line, mine, mill, vessel, fleet, network, data center, warehouse, clinic, store base, or property; a manufacturing, service, or delivery capacity; an approval, license, certification, listing, or qualification that lets the company sell where it previously could not; a distribution footprint, channel, dealer or partner network now in place; a salesforce, clinical team, or field organization already hired and trained; a platform, system, or technology base now operating. What matters is that the capability EXISTS NOW rather than being planned, under construction, or contingent on money the company does not have, and that management treats it as a step-change for a company of this size rather than routine annual expansion or replacement. (2) REAL BUSINESS IS ALREADY FLOWING INTO IT. Management points to concrete, present-tense activity now running through the new capability — first output, first shipments, initial customers, orders being filled, patients or users being served, work being performed, utilization beginning to climb — so the thing is not merely built but demonstrably working. Interest, pipeline, letters of intent, or expected demand do not satisfy this; something must actually be moving through it now. (3) MOST OF THE CAPABILITY IS STILL EMPTY, AND MANAGEMENT SAYS SO. Management conveys, directly or plainly in substance, that the capability is running well below what it can carry — capacity underutilized, sites or lines only partly loaded, the salesforce or approval or footprint only lightly monetized — so that filling it is the live task in front of the company and the reported results reflect the company before it is filled. Management may also describe the cost of carrying it showing up in current results without the corresponding volume. The essence is ONE phenomenon: a company that has just finished buying its next several years of growth capacity, has proven it works by pushing the first real business through it, and now has to fill it — so the incremental business it wins from here lands on costs already incurred. The industry, the form of the capability, and the source of the first business may vary widely. Answer NO if the capability is still being built, hired, permitted, financed, negotiated, or commissioned, with completion an open question rather than an accomplished fact. NO if nothing is yet running through it, so the story rests on a finished asset with no activity behind it. NO if the capability is already substantially loaded, at or near its limits, or already reflected in current results, leaving no meaningful headroom ahead. NO if the addition is routine and small relative to the company — ordinary maintenance, normal replacement, the usual annual cadence of openings — with no sense that the company's ceiling has moved. NO if the underused capability is underused because demand disappeared, the project failed, or management is closing, idling, selling, or writing it down rather than working to fill it. NO if management gives no indication that filling it is something it is actively pursuing now. NO if the only relevant language is generic — "we continue to invest for growth," "we have significant operating leverage," "our model is highly scalable" — without an identifiable capability actually completed and beginning to be used. NO if the idea appears only in an analyst's question or model that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
KE Kimball Electronics, Inc. Q3 2023 2023-05-06 C+
MEC Mayville Engineering Company, Inc. Q3 2022 2022-11-05 B+
FORM FormFactor, Inc. Q4 2021 2022-02-02 B
EHTH eHealth, Inc. Q2 2021 2021-07-29 F

How the model reasoned

FORM · Q4 2021 → YESThe question is: Does management describe that the company has RECENTLY FINISHED PUTTING IN PLACE A CAPABILITY THAT IS LARGE RELATIVE TO THE COMPANY ITSELF, and that real business has ALREADY BEGUN FL...YES The transcript shows management describing the Livermore Manufacturing Center as a completed capability (purchased building, tools installed, shipments begun in Q4, revenue contribution noted) that is large relative to the company (part of $850M+ target model and beyond). Real business is flowing in (shipments started, revenue impact 4Q), while most of the capability remains unused (only half the building fitted out, gradual ramp via tools/labor, second half still in planning). This matches the three conditions exactly. Other expansions are mentioned but the Livermore detail is the clearest fit.
EHTH · Q2 2021 → YESThe question is: Does management describe that the company has RECENTLY FINISHED PUTTING IN PLACE A CAPABILITY THAT IS LARGE RELATIVE TO THE COMPANY ITSELF, and that real business has ALREADY BEGUN FL...YES The transcript shows management describing a step-change internal telesales capability (90% full-time agents, cloud-based contact center, mandatory training, verification agents, QA enhancements) that is now largely finished and paid for, with real business (Medicare enrollments) already flowing through it while most of the new capacity sits underutilized ahead of AEP. They explicitly note peak headcount in Q3 with many agents still in training and not at full productivity, confirming the unused headroom. This matches all three conditions in one coherent situation.
MEC · Q3 2022 → YESThe question is about whether management describes a recently finished large capability that's now starting to have real business flowing into it, but most of it is still unused. YES The transcript shows management describing the Hazel Park facility as a completed, state-of-the-art capability that has just begun production ("commenced production...

More from the question bank

Personal bests piling upStrong facts, held-back storyQuietly replacing the old wayFresh change already executed, benefit mostlOrder-of-magnitude gapSomebody else pays firstAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.